British Patient Capital's investment focus is on providing long-term, patient capital to innovative UK companies, particularly those in the venture growth stage, to help them scale up. Their strategy involves investing in UK venture capital funds and directly co-investing alongside fund managers, with a particular interest in sectors such as sustainability, life sciences, and deep tech, all while operating on a commercial basis to achieve competitive returns.
Average disclosed round size is $77.6M (across 21 rounds with reported amounts).
Portfolio
21
Fund Size
$3.2B
Top Stage
Series C
Last 12 Mo
0
Team
TH
Tom Haywood
Managing Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
21 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Maxion Therapeutics | Series A | $72M | Mar 2025 |
 Quantexa | Series F | $175M | Mar 2025 |
 Cambridge GaN Devices | Series C | $30.5M | Feb 2025 |
| TTokamak Energy | Series D | $125M | Nov 2024 |
| TTokamak Energy | Series C | $75M | Nov 2024 |
 Nuclera | Series C | $75M | Oct 2024 |
 Purespring Therapeutics | Series B | $105M | Oct 2024 |
| FForm3 | Series C | $60M | Sep 2024 |
 Wagestream | Series B | $20.4M | Apr 2024 |
 Phagenesis | Series D | $42M | Mar 2024 |
 Curve Therapeutics | Series A | $51.4M | Feb 2024 |
 Tenpoint Therapeutics | Series A | $70M | Jul 2023 |
| Quantexa | Series E | $129M | Apr 2023 |
 CyberSmart | Series B | $15.4M | Feb 2023 |
 Quantum Motion | Growth | $51M | Feb 2023 |
| Quantum Motion | Series C | $50.5M | Feb 2023 |
 Perspectum | Series C | $36M | Jan 2023 |
 Oxford Quantum Circuits | Series A | $46M | Jul 2022 |
| Oxford Quantum Circuits | Series A | $47M | Jul 2022 |
| TThought Machine | Series C | $200M | Nov 2021 |
| Quantexa | Series D | $153M | Jul 2021 |
Top Co-Investors
Oxford Science Enterprises4 shared
IQ Capital3 shared
Parkwalk Advisors3 shared
Sofinnova Partners2 shared
BGF2 shared
Cambridge Innovation Capital2 shared
Lansdowne Partners2 shared
Oxford Investment Consultants2 shared
Warburg Pincus2 shared
Dawn Capital2 shared
AlbionVC2 shared
Evolution Equity Partners2 shared
HSBC2 shared
ABN AMRO Ventures2 shared
Octopus Ventures2 shared
Bosch Ventures2 shared
INKEF Capital2 shared
IP Group2 shared
Gilde Healthcare1 shared
Last updated: 12 April 2026